|

- 积分
- 279
- 威望
- 279
- 包包
- 128
|

Title: CD133: molecule of the moment.6 r0 h1 a- P! `
Author: Mizrak, D.; Brittan, M.; Alison, M. R.# P& Z. H& z+ l% Q# C
Source: J Pathol, 2008, 214(1): 3-9* }( L6 U- u' s4 m" C! n3 W1 l1 I8 a
+ Z, {5 s) w' E. k6 S; I1 V; r
Title: Focus on molecules: prominin-1 (CD133).
! |+ \+ Q* ?8 A5 j2 SAuthor: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)
2 X' {( a; u& q) N K5 ?Source: Exp Eye Res, 2007, 85(5): 585-586" ^/ B( ?8 _/ J s, a) S
0 X$ K' W. R% |( YTitle: CD133.
2 X( S' t7 H+ r9 sAuthor: Piechaczek, C.3 B1 j9 g) I k8 z, P/ b& N
Source: J Biol Regul Homeost Agents, 2001, 15(1): 101-1024 }0 Z0 ^6 k% d m' c: m9 ^ d+ Y
) a; Y6 {. L" J4 zTitle: CD133 as a marker for cancer stem cells: progresses and concerns.. M1 h4 |2 j/ S7 w! y# V
Author: Wu, Y.; Wu, P. Y.7 ?1 r, P( g4 T) C* K
Source: Stem Cells Dev, 2009, 18(8): 1127-11345 e3 c: a0 f$ u1 F
! X$ [; {5 z$ V
Title: Risk and benefit of CD133+ progenitors.
- I$ g9 |; a+ X) n0 q' JAuthor: Ascione, R.; Madeddu, P.
5 ]2 ~: F! s# x% I& A4 w2 ]+ zSource: Circ Res, 2009, 105(2): e2
" N! m" Z# X! J7 h& ?5 S. _
( T' P7 _ I; g" r& @Title: Targeting CD133 antigen in cancer.) L" K6 i( p5 z5 W; P w
Author: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...)
1 K: e+ o# y3 FSource: Expert Opin Ther Targets, 2009, 13(7): 823-8378 L2 k8 D: r* |) ]+ r: y/ H/ g( j
" k, t# Z5 X6 y; D" m- hTitle: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.& u- L4 p* S0 F n% J. t
Author: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...)
! s- g1 V4 l+ i; ~1 O5 L+ K0 KSource: Neurosurgery, 2008, 62(2): 505-514, 514-515 |
|